1. ABCG2 and CD200 define patients at high risk of relapse in ELN favorable subgroup of AML. (20th July 2017) Authors: Tiribelli, Mario; Geromin, Antonella; Cavallin, Margherita; Di Giusto, Sara; Simeone, Erica; Fanin, Renato; Damiani, Daniela Journal: European journal of haematology Issue: Volume 99:Number 3(2017) Page Start: 269 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients. Issue 10 (23rd July 2013) Authors: Damiani, Daniela; Tiribelli, Mario; Franzoni, Alessandra; Michelutti, Angela; Fabbro, Dora; Cavallin, Margherita; Toffoletti, Eleonora; Simeone, Erica; Fanin, Renato; Damante, Giuseppe Journal: American journal of hematology Issue: Volume 88:Issue 10(2013:Oct.) Page Start: 848 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical outcome of myeloid sarcoma in adult patients and effect of allogeneic stem cell transplantation. Results from a multicenter survey. (February 2017) Authors: Lazzarotto, Davide; Candoni, Anna; Filì, Carla; Forghieri, Fabio; Pagano, Livio; Busca, Alessandro; Spinosa, Giuseppina; Zannier, Maria Elena; Simeone, Erica; Isola, Miriam; Borlenghi, Erika; Melillo, Lorella; Mosna, Federico; Lessi, Federica; Fanin, Renato Journal: Leukemia research Issue: Volume 53(2017:Feb.) Page Start: 74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Complete and long‐lasting cytologic and molecular remission of FIP1L1‐PDGFRA‐positive acute eosinophil myeloid leukaemia, treated with low‐dose imatinib monotherapy. (19th February 2014) Authors: Barraco, Daniela; Carobolante, Francesca; Candoni, Anna; Simeone, Erica; Piccaluga, Pierpaolo; Tabanelli, Valentina; Fanin, Renato Journal: European journal of haematology Issue: Volume 92:Number 6(2014:Jun.) Page Start: 541 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Flai (fludarabine, cytarabine, idarubicin) plus low‐dose Gemtuzumab Ozogamicin as induction therapy in CD33‐positive AML: Final results and long term outcome of a phase II multicenter clinical trial. Issue 5 (2nd March 2018) Authors: Candoni, Anna; Papayannidis, Cristina; Martinelli, Giovanni; Simeone, Erica; Gottardi, Michele; Iacobucci, Ilaria; Gherlinzoni, Filippo; Visani, Giuseppe; Baccarani, Michele; Fanin, Renato Journal: American journal of hematology Issue: Volume 93:Issue 5(2018:May) Page Start: 655 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. High CD200 expression is associated with poor prognosis in cytogenetically normal acute myeloid leukemia, even in FlT3-ITD-/NPM1+ patients. (July 2017) Authors: Tiribelli, Mario; Raspadori, Donatella; Geromin, Antonella; Cavallin, Margherita; Sirianni, Santina; Simeone, Erica; Bocchia, Monica; Fanin, Renato; Damiani, Daniela Journal: Leukemia research Issue: Volume 58(2017:Jul.) Page Start: 31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Multicentre survey to explore current survival of patients with acute myeloid leukaemia who failed induction chemotherapy. (17th August 2015) Authors: Lazzarotto, Davide; Candoni, Anna; Nadali, Gianpaolo; Pavan, Laura; Lessi, Federica; Mosna, Federico; Simeone, Erica; Ventura, Giovanna; Gherlinzoni, Filippo; Semenzato, Gianpietro; Pizzolo, Giovanni; Fanin, Renato Journal: European journal of haematology Issue: Volume 96:Number 6(2016:Jun.) Page Start: 586 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗